A FATHER'S CONTRIBUTION TO his children's risk of birth defects is not well established.
If the father has a birth defect, he may pass on to his children genes that increase their risk of a birth defect. However, the extent to which children of affected males are at higher risk is unknown except in a few specific types of birth defects. Furthermore, if a father has a particular birth defect, it is unknown whether his offspring are at increased risk of having any other kinds of birth defects.
We observed a cohort of nearly a half million males from birth to adulthood, using a population-based registry in Norway. Males with registered birth defects were compared with other males regarding survival, their probability of having offspring, and risk of birth defects in their offspring. We have previously reported similar data for a cohort of females with birth defects.
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METHODS
Population-Based Cohort
The population-based Medical Birth Registry of Norway records all births in Norway since 1967 (about 1.8 million births). All live births and stillbirths at a gestational age of at least 16 weeks are included in the registry. There were 486207 live and stillborn male infants delivered in Norway between 1967 and 1982, which we defined as our study cohort. In our analyses, the cohort was divided into those with a registered birth defect (n=12292 males [2.5%] ) and the remaining males without birth defects (the reference group). The cohort was followed up for survival through 1992, when the most recent linkage with mortality records was carried out, and for reproduction through September 1998.
Linking Fathers and Offspring
The Medical Birth Registry of Norway includes unique personal identification numbers for all births in Norway as well as the identification number of the father and mother. These identifiers permit linkage of males born early in the cohort with their offspring born later (1983) (1984) (1985) (1986) (1987) (1988) (1989) (1990) (1991) (1992) (1993) (1994) (1995) (1996) (1997) (1998) ). This linkage does not ensure 100% detection of the cohort's offspring. During the later period, 5.6% of the births lacked a father's identity and, therefore, were excluded from this analysis. The lack of identified fathers was associated with fetal death; the percentage of stillbirths that did not have an identified father was 51%. Also, younger mothers were more likely to have children with an unidentified father, which presumably led to selective loss of recorded births for younger fathers. Finally, children born outside of Norway to Norwegian-born parents are not captured by the registry (although outmigration during this period was extremely low 2 ). By 1998, the registry had accumulated 110327 births that could be linked to fathers born in the study cohort.
Classification of Birth Defects
The Medical Birth Registry of Norway records birth defects that are diagnosed at delivery or by pediatric examination during the initial hospitalization (Ն5 days). In this study, 24 categories of birth defects were used, the same as in 2 previous studies. 1, 3 Categories of birth defects were based on the 3-digit codes of the International Classification of Diseases, Eighth Revision (ICD-8), with minor modifications. Most of the birth defects included are major; however, minor defects may be included in some categories and cannot be distinguished by ICD-8 codes. For example, the heterogeneous category of limb defects includes serious reduction deformities and, possibly, minor soft-tissue syndactylies.
Most affected children had only 1 specific birth defect diagnosis. Cases with multiple defects were pooled in a separate category, except that when spina bifida was present with anencephaly, only anencephaly was counted, and when hydrocephalus was present with spina bifida, only spina bifida was counted. Isolated cleft palate was separated from the 3-digit ICD-8 code for cleft lip and palate as a distinct category. Similarly, Down syndrome was separated as a category distinct from other syndromes.
The Medical Birth Registry of Norway, like other registries based on routine medical birth records, does not capture all birth defects. Estimates of ascertainment vary by defect category. For example, the Medical Birth Registry of Norway captures an estimated 80% of cleft lip and an estimated 60% of Down syndrome cases. 4 The Norwegian Health Inspectorate has instructed that therapeutic abortions should be reported to the registry as stillbirths, including information on any diagnoses of birth defects. The completeness of such reporting is not known, however.
In analyzing the risk of birth defects in children whose fathers also had birth defects, we defined a similar defect as one in the same ICD-8 category as the father's and other defects as all others. 
Analysis
Males with birth defects were compared with males without birth defects. Survival and reproduction were based on standard actuarial life-table methods (6-month intervals). Reproduction among males with specific birth defects was calculated as a ratio relative to males who had no reported birth defects, with the inherent limitation of a slight underascertainment of offspring. Estimates of reproduction are based on all males surviving to age 15 years. The 95% confidence interval (CI) for relative reproduction between groups was calculated using a Cox proportional hazards model. 5 The expected number of birth defects in offspring of fathers with a specific defect was based on risk of birth defects among offspring of males without recorded birth defects. Relative risks (RRs) of recurrence of similar or dissimilar birth defects (the observed-expected ratio [O/E]) were summarized across all paternal defect categories using a stratified approach. Exact P values and 95% CIs were calculated using StatXact. Age, y Cumulative Reproduction, %
Reproduction
B
The cohort was followed up for survival through 1992 and for reproduction through September 1998. Reproduction data were analyzed only among survivors. *Follow-up was completed through September 1998. †Survival was followed up through 1992. ‡Reproduction data are expressed as the percentage of survivors who became fathers by September 1998.
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RESULTS
The prevalence of registered defects at birth (including stillbirths) was 2.5% in this cohort of 486207 males. Eighteen percent (n=85574) of survivors had at least 1 recorded offspring by September 1998 (TABLE 1) . The percentage who had become fathers increased with age, reaching 46% by age 28 to 31 years.
Survival and Reproduction Among Males With Birth Defects
FIGURE 1A
shows survival for males with and without birth defects. Males with a birth defect had lower survival to age 20 years (84% compared with 97%, including all male fetuses aged Ն16 completed weeks' gestation). Affected males had higher mortality at all ages up to 14 years, with the highest RR in the first year of life (TABLE 2) . If they survived, males with birth defects were less likely than other males to have a child at any age ( Figure 1B ). Using a Cox regression model, the rate of reproduction among surviving males with birth defects was estimated to be 72% of the reproduction rate among unaffected males (95% CI, 68%-77%). Taking into account both the higher mortality rates and the lower reproduction rates among survivors, a male with birth defects was, on average, only 63% as likely to reproduce by age 30 years as an unaffected male. FIGURE 2 shows total survival for each of the 24 birth defect categories and reproduction among males in each category relative to unaffected males. The defects that were least likely to cause death were also least likely to reduce a man's probability of having a child if he survived. However, some birth defect categories with high survival rates had substantially reduced reproduction rates and vice versa.
Birth Defects in the Second Generation
Of the 12 292 males with birth defects, 850 had a total of 1265 children. Sixty-four (5.1%) of these children had birth defects. Fathers without birth defects had a total of 109162 children, of whom 2326 (2.1%) had birth defects.
Thus, the overall risk of a birth defect was 2.4 times higher among children of affected fathers (95% CI, 1.9-3.0). This higher risk of birth defects did not differ by sex of the offspring (P=.79).
The excess contribution made by affected fathers to occurrence of birth defects in the next generation was a combination of 2 factors: the proportion of fathers who had birth defects and the increased risk of defects in their children. Measured in attributable risk, 7 affected fathers contributed 16 of 1000 registered birth defects in the next generation. Defect-specific reproduction is reported relative to reproduction of males without birth defects. Reproduction data were analyzed only among survivors. 
Similarity of Defects in Fathers and Children
from the father's compared with an expected number of 23.7. The O/Es for specific defects were all greater than 1 and, for 2 categories (cleft lip and abdominal wall), this increase was statistically significant. The pooled O/E for a dissimilar defect was 1.8 (95% CI, 1.3-2.5).
COMMENT
The Medical Birth Registry of Norway is a population-based registry that permits follow-up of persons born since 1967. In a previous article, we identified a cohort of females born between 1967 and 1982 and compared the survival and reproduction of females with and without birth defects. 1 In the present article, we provide similar data for males with and without birth defects.
Males with birth defects had higher mortality than unaffected males through infancy and childhood. This surprising persistence of mortality risk presumably reflects the ongoing complications related to their defects.
Males with birth defects were 28% less likely than unaffected males to have a child. This presumably reflects social as well as biological consequences of their defects. The reduced probability of fathering a child varied substantially across defect categories, with all but the small category of other central nervous system defects having a reduced tendency to reproduce.
The total risk of birth defects was 5.1% among offspring of fathers with defects and 2.1% among offspring of fathers without defects, for an RR of 2.4. No single category of defect explained the higher risk in affected fathers' offspring.
As expected, the risk of birth defects in offspring was increased mainly for the same type of defect as the father's. Fairly precise estimation of the recurrence risk was possible for the most common types of defects. A recurrence risk of the same defect is consistent with a shared genetic etiology, although shared environmental causes cannot be ruled out. Offspring of affected fathers also had an increased risk of dissimilar defects of all types. The explanation for this excess is not as clear, and the possibility of bias must be considered.
The Medical Birth Registry of Norway, like other registries based on routine medical birth records, does not capture all birth defects. Some are simply underregistered at birth. 4 Others, such as defects of the heart or kidney, are often ascertained too late to be captured by the registry. This is reflected in the relatively low number of such defects in our data.
Underregistration creates an opportunity for bias. A father's birth defect may make it more likely that a birth defect in his offspring would be recorded in the medical record. If so, we would predict that, on average, these recorded defects would tend to be milder. This was apparently not the case. Among the 64 affected offspring of affected fathers, 9.4% died within the first year of life, while among the 2326 affected offspring with unaffected fathers, only 5.9% died in the first year. It appears that affected offspring of affected fathers had more serious defects compared with affected offspring of unaffected fathers. A tendency for more minor defects to be ascertained in offspring of affected fathers is possible but could not be demonstrated.
Our previous analysis of affected mothers provides some further information on the issue of selective diagnosis. Previously, we found no increase among the offspring of affected mothers in the RR for dissimilar defects. 1 An increased ascertainment of defects would presumably occur among offspring regardless of which parent was 
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affected. Thus, we observed no evidence to support ascertainment bias as the reason for an excess of dissimilar defects among offspring of affected fathers.
If male neonates are routinely inspected more closely for defects than female neonates, this could lead to ascertainment of more minor defects for males within each defect category. If such minor defects had a stronger tendency to result in a dissimilar defect in offspring, this could contribute to a higher risk in offspring of affected fathers. Some children with 1 registered birth defect probably also have other unascertained birth defects. If such underascertainment were more frequent for males, this also could lead to an increased risk of apparently dissimilar defects.
Although the recurrence risk from father to offspring was substantial, the number of affected fathers was too low to contribute many birth defects to the next generation. Only 1.6% of birth defects in the second generation could be attributed to a defect in fathers. Males with birth defects were slightly more likely than other males to find a partner with a birth defect (1.6% vs 0.9%). However, this difference is too small to explain the excess risk of dissimilar defects. Of the 15 pairs of parents in which both had birth defects, only 1 had an affected child (father, mother, and child all had cleft lip).
Given the structure of the cohort (comprising all male births in 1967-1982), only a small proportion of the members of the cohort have reached age 31 years. Caution must be used in making longitudinal interpretations of these cross-sectional data. A complete reproductive history will be required to make a more definitive inference about male reproduction and risk of birth defects in offspring.
This study had incomplete ascertainment of offspring among males in the cohort. During the period when these births occurred, nearly 6% of birth certificates had no recorded father and, as a consequence, some males in the cohort became fathers without evidence in the registry. Since the father's information was lacking for half of stillbirths, and children with birth defects are more likely than others to be stillborn, the total number of children with birth defects born to the study cohort of males is probably underascertained.
Furthermore, offspring of affected fathers may be selectively underascertained to the extent that these offspring more often have birth defects and, therefore, more often are stillborn. The effect could be that we slightly underestimate the fertility of affected fathers and, more importantly, that we may underestimate the percentage of birth defects among their offspring.
For an unknown percentage of birth certificates, the recorded father is not the biological father. Such errors would reduce the contrast in rates of recurrence between affected and unaffected males.
Our estimates of recurrence risk do not take into account the slight statistical dependence of outcomes within the family structure, ie, that some fathers are represented with more than 1 child. 8 While this may widen some CIs, the effects are minimal and should have little or no impact on the risk estimates themselves. The results were similar when analyses were restricted to only 1 (the first) child per father.
There are similarities but also apparent dissimilarities between these data for males and the data for females reported previously.
1 Birth defects generally were more prevalent among males than females. This male excess of defects also has been observed in other cohorts. 9 Infant and childhood mortality rates were lower for affected males than for affected females (16% vs 20%).
1 This counters the usual survival advantage of females in infancy and childhood. The higher mortality for affected females was not explained by any specific category of defects. Given the higher rate of recorded defects among males, it is possible that less severe manifestations of a given defect are more likely to be registered for males than for females.
The 28% reduced reproduction tendency among affected males is very similar to the reduction previously seen among affected females (27%). 1 Given that reproduction is a more complex function for mothers than for fathers, we might have expected a smaller reduction among affected males. Similarly, if the excess birth defects among males reflect the selective recording of a greater number of milder defects, we might have expected less reproductive impairment among males than females. Neither was the case.
Affected males were slightly more likely than affected females to contribute offspring to the next generation (63% vs 60%). Given that more males than females had registered birth defects, there were substantially more affected fathers than affected mothers contributing to the next generation. This result was not fully apparent at the follow-up in 1998 because males tend to become parents later in life than females, and the present data are truncated at a relatively young age.
The RR for birth defects among offspring was significantly higher for affected males (2.4) than for affected females (1.6) (test of homogeneity of odds ratios, P = .03). This difference hypothetically may be explained by a greater contribution of paternal genes to risk of birth defects (genomic imprinting).
The pooled RR of a woman having a child with the same defect was 6.8, 1 similar to the father's risk of 6.5. However, affected mothers had no apparent increase in risk of offspring with other defects (RR, 1.0), 1 in contrast with the substantial increase in the father's risk of other defects (RR, 1.8). The higher risk of dissimilar defects with affected fathers apparently accounts for the entire excess of birth defects among offspring of affected fathers compared with offspring of affected mothers. A syndrome could hypothetically be expressed as different defects in different affected family members. It is unclear whether this could explain a higher tendency of males to pass on a different defect to the next generation.
There are few data in the literature that compare recurrence risk for fathers and mothers, and these data are restricted to recurrence of the same defect carried by the parent. Mothers have been reported to be more likely than fathers to pass on a heart defect to a child. 10, 11 In a study of spina bifida, mothers of affected children were more likely than fathers to report a family history of spina bifida. 12 The authors interpret this as evidence of preferential transmission of these defects through females, although this could also be because of more complete reporting by mothers.
Affected males contributed more affected offspring than affected females, not merely because of their increased risk of having affected offspring but because there were more affected fathers than mothers. The attributable risk of birth defects in the next generation from affected fathers was 3 times that from affected mothers (1.6% vs 0.5%). 1 The sum of 2 attributable risks is usually an overestimate of their total, so the combined contribution from affected parents is presumably no more than 2%.
In this report, we have shown that males with birth defects have increased mortality throughout childhood compared with unaffected males and that males with birth defects are less likely to have a child. Furthermore, our data suggest that fathers with birth defects are significantly more likely than unaffected fathers to have children with birth defects. In many respects, these findings are similar to previously published data for females. However, affected fathers appear to contribute more birth defects than affected mothers to the next generation.
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